Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

1,850.00p
   
  • Change Today:
      20.00p
  • 52 Week High: 3,750.00p
  • 52 Week Low: 1,800.00p
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 3,565
  • Market Cap: £96.66m

Latest Deals

Traded Action Notifier PriceAmountValue
25-Nov-25 Buy Bruce Hiscock 2,071.00p 150 £3,106.50

Largest Deals (28 days)

Traded Action Notifier PriceAmountValue
25-Nov-25 Buy Bruce Hiscock 2,071.00p 150 £3,106.50

Director Shareholdings

Notifier Holding Value*
Peter John Harrison 304,042 £5,624,777
Ian James Nicholson 13,500 £249,750
Bruce Hiscock 1,474 £27,269

Major Shareholders

Notifier** Holding Value*
Rathbones Investment Management Ltd 5,219,656 £96,563,636
Castlefield Fund Partners Limited 985,000 £18,222,500
SANFORD DELAND ASSET MANAGEMENT LTD 885,000 £16,372,500
Gresham House Asset Management Limited 627,782 £11,613,967
SANFORD DELAND ASSET MANAGEMENT LTD 619,500 £11,460,750
Miton Group plc 508,135 £9,400,498
The Diverse Income Trust plc 302,300 £5,592,550
Schroders plc 284,795 £5,268,708
Wasatch Advisors, Inc. 265,000 £4,902,500
Raymond James Wealth Management Limited 263,770 £4,879,745
Premier Miton Group plc 262,812 £4,862,022
Canaccord Genuity Group Inc 259,940 £4,808,890
Adrian Williams 253,372 £4,687,382

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 1,850.00p
Change Today 20.00p
% Change 1.09 %
52 Week High 3,750.00p
52 Week Low 1,800.00p
Volume 3,565
Shares Issued 5.22m
Market Cap £96.66m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
23.47% above the market average23.47% above the market average23.47% above the market average23.47% above the market average23.47% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
67.33% below the market average67.33% below the market average67.33% below the market average67.33% below the market average67.33% below the market average
31.82% below the sector average31.82% below the sector average31.82% below the sector average31.82% below the sector average31.82% below the sector average
Income
60.89% above the market average60.89% above the market average60.89% above the market average60.89% above the market average60.89% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Growth
5.71% below the market average5.71% below the market average5.71% below the market average5.71% below the market average5.71% below the market average
65.52% below the sector average65.52% below the sector average65.52% below the sector average65.52% below the sector average65.52% below the sector average

Bioventix Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 06-Nov-25 10-Apr-25
Paid 21-Nov-25 25-Apr-25
Amount 80.00p 70.00p

Trades for 08-Dec-2025

Time Volume / Share Price
16:25 15 @ 1,802.00p
15:03 35 @ 1,850.00p
15:40 100 @ 1,830.00p
15:30 13 @ 1,802.00p
15:10 129 @ 1,830.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page